Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases.  Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology.  Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability.  Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research.  Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare.  Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field.  Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index. As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 11 PhD candidates, nurturing the next generation of scientific leaders. Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards. Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications. In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.

Victor S Selvanayagam completed his degree in Sports Science and Master’s in Medical Science at the University of Malaya (UM). He received his PhD from The University of Queensland in the area of Neuroscience where he focused on identifying early neural responses to strength training. Victor, who is also a Certified Strength and Conditioning specialist (CSCS), is currently an Associate Professor and was the Deputy Director (Research and Development) with the Faculty of Sports and Exercise Science, Universiti Malaya. He played a pivotal role in developing and is currently the coordinator for the first Master of Strength and Condtioning Program in Malaysia. His main research focuses on the contribution of the nervous system to strength by incorporating well-explored motor learning paradigms to strength training. He also plays a consultative role in the area of exercise physiology and exercise testing and prescription. Ultimately, Victor is keen to explore and share his expertise pertaining to the science and fundamentals of human movement, so that movements can be safe, effective and efficient.  Updated 09/05/2025 (WOS) Total Articles in Publication List  23 Articles With Citation Data  21 Sum of the Times Cited   302 h-index   8

Dr. Teo Chee How received his Doctor of Philosophy from the University of Leicester, the United Kingdom where his research was focusing on the distribution and diversity of repetitive DNAs in the Musa genome. He was involved in the development of retrotransposon-based molecular markers for Musa species identification. During his stays at the University of Leicester, he was involved in the fifth EU framework programme where, together with other partners in the framework, he developed universal tools to isolate pararetroviruses (EPRVs) and investigate the biodiversity of EPRV sequences. In addition, he successfully established a plant artificial minichromosome platform for crop improvement purposes during his post-doctorate period at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany. In 2012 he returned to Malaysia to work at Agro-Biotechnology Institute (ABI) under the Ministry of Science, Technology, and Innovation (MOSTI) as a Senior Research Officer before joining academic as Senior Lecturer at Taylor’s University in 2014. He joined the Centre for Research in Biotechnology for Agriculture (CEBAR), the University of Malaya as a Senior Lecturer in 2016.